SOTIO makes several additions to advisory board SOTIO makes several additions to advisory board The company has hired three clinical oncology research experts and biotechnology business development and commercialisation professionals Doloromics appoints Chief Research and Development Officer Doloromics appoints Chief Research and Development Officer "I’m both thrilled and privileged to commit the full measure of my expertise and passion in executing the core mission of Doloromics" Rentschler appoints General Manager of UK ATMP unit Rentschler appoints General Manager of UK ATMP unit Dr Robert Panting joins the company from Fujifilm Diosynth Biotechnologies, where he worked in project management, customer management and business planning Aslan Pharmaceuticals makes appointments to scientific board Aslan Pharmaceuticals makes appointments to scientific board Dr Melinda Gooderham, Dr Jacob Thyssen and Associate Professor Peter Foley will all join the company’s scientific advisory board Nanoform to elect Jeanne Thoma as board member Nanoform to elect Jeanne Thoma as board member Thoma spent the first part of her career at BASF in New Jersey, USA, where she rose to leadership positions in the pharmaceutical ingredients business CosmoTrace appoints ex-TraceLink VP to lead in North America CosmoTrace appoints ex-TraceLink VP to lead in North America Matt Ricketson brings more than 30 years experience in professional services and business development Optibrium appoints Prof Andy Black non-executive chair Optibrium appoints Prof Andy Black non-executive chair Prior to his current roles, Black co-founded Kinapse, an international business providing expert advisory and implementation services to life science industries Rentschler Biopharma appoints Chief Scientific Officer Rentschler Biopharma appoints Chief Scientific Officer ith more than 30 years of experience in biotechnological science and in the life sciences industry as well as in various executive and supervisory board functions, Schetter has... Pfizer announces appointment of Chief Business Innovation Officer Pfizer announces appointment of Chief Business Innovation Officer Malik succeeds John Young, who recently announced his intent to retire after a 34-year career at Pfizer. Mr. Malik begins his role on August 30, 2021 and will work with John to... Centrient Pharmaceuticals announces Non-Executive Supervisory Board appointment  Centrient Pharmaceuticals announces Non-Executive Supervisory Board appointment  Manja Boerman is the President of Catalent Cell & Gene Therapy with overall responsibility for strategy and leadership of the cell and gene businesses Philippe Deecke appointed Chief Financial Officer of Lonza Group Philippe Deecke appointed Chief Financial Officer of Lonza Group Deecke joins the company from Novartis, where he held a series of senior finance positions Avacta appoints Chief Scientific Officer of therapeutics division Avacta appoints Chief Scientific Officer of therapeutics division Dr Alastair Smith, CEO of Avacta Group, commented: “We are delighted to have Fiona McLaughlin join us as Chief Scientific Officer of our therapeutics division Dante Labs appoints Mark Van Oene to board of directors Dante Labs appoints Mark Van Oene to board of directors Van Oene said: “I’m excited to be joining Dante’s board in order to help scale the business as the need for genomics in healthcare is realised Ori Biotech expands board of directors and scientific advisory board Ori Biotech expands board of directors and scientific advisory board Dr Annalisa Jenkins will join Ori’s board of directors, and Robert Preti will join its scientific advisory board Dotmatics appoints Michael Swartz as SVP Enterprise Product Dotmatics appoints Michael Swartz as SVP Enterprise Product Prior to the appointment, Swartz was VP of Software Solutions and Strategy at PerkinElmer Informatics, where he led strategic planning and execution for the company’s product... Avacta appoints Dr Mark Goldberg as Non-Executive Director Avacta appoints Dr Mark Goldberg as Non-Executive Director Goldberg currently serves on the boards of directors of ImmunoGen, Idera Pharmaceuticals, GlycoMimetics, Walden Biosciences, and Blueprint Medicines